Average Co-Inventor Count = 13.30
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (14 from 1,149 patents)
2. Rqx Pharmaceuticals, Inc. (5 from 6 patents)
3. Novartis Ag (3 from 3,923 patents)
4. Genentech, Inc. (2 from 3,221 patents)
5. Irm LLC (1 from 151 patents)
22 patents:
1. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
2. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator
3. 12319693 - Crystalline forms of CFTR modulators
4. 12269831 - Modulators of cystic fibrosis transmembrane conductance regulator
5. 12122788 - Process of making CFTR modulators
6. 11873300 - Crystalline forms of CFTR modulators
7. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
8. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator
9. 11584761 - Process of making CFTR modulators
10. 11453655 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
11. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
12. 11072635 - Macrocyclic broad spectrum antibiotics
13. 11066417 - Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
14. 10793547 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
15. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator